{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:24:57Z","timestamp":1787934297743,"version":"build-2784847793"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["20214Y0013"],"award-info":[{"award-number":["20214Y0013"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073032"],"award-info":[{"award-number":["82073032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972599"],"award-info":[{"award-number":["81972599"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173276"],"award-info":[{"award-number":["82173276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073037"],"award-info":[{"award-number":["82073037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203237,81872243"],"award-info":[{"award-number":["82203237,81872243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0107500"],"award-info":[{"award-number":["2018YFA0107500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFA0504503"],"award-info":[{"award-number":["2017YFA0504503"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cbi.2024.111015","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T02:53:25Z","timestamp":1713840805000},"page":"111015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Lipopolysaccharide modification enhances the inhibitory effect of clodronate liposomes on hepatic fibrosis by depletion of macrophages and hepatic stellate cells"],"prefix":"10.1016","volume":"395","author":[{"given":"Luyao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.cbi.2024.111015_bib1","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/liv.14940","article-title":"Hepatic macrophages: key players in the development and progression of liver fibrosis","volume":"41","author":"Cheng","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.cbi.2024.111015_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies","volume":"68\u201369","author":"Schuppan","year":"2018","journal-title":"Matrix Biol."},{"issue":"1","key":"10.1016\/j.cbi.2024.111015_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.cbi.2024.111015_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: unmet needs and a blueprint for the future","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"10.1016\/j.cbi.2024.111015_bib5","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: concept to treatment","volume":"62","author":"Trautwein","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.111015_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coph.2019.09.006","article-title":"New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseases","volume":"49","author":"Lemoinne","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/j.cbi.2024.111015_bib7","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cbi.2024.111015_bib8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"issue":"19","key":"10.1016\/j.cbi.2024.111015_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201704307","article-title":"Biodistribution, clearance, and long-term fate of clinically relevant nanomaterials","volume":"30","author":"Bourquin","year":"2018","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.cbi.2024.111015_bib10","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1039\/C5CS00699F","article-title":"In vivo degeneration and the fate of inorganic nanoparticles","volume":"45","author":"Feliu","year":"2016","journal-title":"Chem. Soc. Rev."},{"issue":"11","key":"10.1016\/j.cbi.2024.111015_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0167-5699(98)01319-X","article-title":"Neutrophil-Kupffer-cell interaction in host defenses to systemic infections","volume":"19","author":"Gregory","year":"1998","journal-title":"Immunol. Today"},{"key":"10.1016\/j.cbi.2024.111015_bib12","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3389\/fimmu.2020.01169","article-title":"Crosstalk between liver macrophages and surrounding cells in nonalcoholic steatohepatitis","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cbi.2024.111015_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.cbi.2024.111015_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cells8091032","article-title":"Phenotypical and functional polymorphism of liver resident macrophages","volume":"8","author":"Elchaninov","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cbi.2024.111015_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108051","article-title":"Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis","volume":"99","author":"Yang","year":"2021","journal-title":"Int. Immunopharm."},{"issue":"6","key":"10.1016\/j.cbi.2024.111015_bib16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/hepr.13317","article-title":"Vitamin A-coupled liposomal Rho-kinase inhibitor ameliorates liver fibrosis without systemic adverse effects","volume":"49","author":"Okimoto","year":"2019","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cbi.2024.111015_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cbi.2024.111015_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-4939-7837-3_23","article-title":"Depleting macrophages in vivo with clodronate-liposomes","volume":"1784","author":"Moreno","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2024.111015_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(96)00034-8","article-title":"Biodistribution of clodronate and liposomes used in the liposomes mediated macrophage 'suicide' approach","volume":"192","author":"Buiting","year":"1996","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"10.1016\/j.cbi.2024.111015_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/10611869408996810","article-title":"Liposomes mediated depletion of macrophages: an approach for fundamental studies","volume":"2","author":"Buiting","year":"1994","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.cbi.2024.111015_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-0030-1255353","article-title":"Toll-like receptor 4 and hepatic fibrogenesis","volume":"30","author":"Pradere","year":"2010","journal-title":"Semin. Liver Dis."},{"issue":"2","key":"10.1016\/j.cbi.2024.111015_bib22","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15027419","article-title":"Expression of toll-like receptors in hepatic cirrhosis and hepatocellular carcinoma","volume":"15","author":"Sun","year":"2016","journal-title":"Genet. Mol. Res."},{"issue":"11","key":"10.1016\/j.cbi.2024.111015_bib23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2024.111015_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","article-title":"Lipopolysaccharide endotoxins","volume":"71","author":"Raetz","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.cbi.2024.111015_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.canlet.2021.05.039","article-title":"Oncostatin M promotes hepatic progenitor cell activation and hepatocarcinogenesis via macrophage-derived tumor necrosis factor-alpha","volume":"517","author":"Yang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2024.111015_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0076-6879(03)73001-8","article-title":"In vivo\" depletion of macrophages by liposomes-mediated \"suicide","volume":"373","author":"van Rooijen","year":"2003","journal-title":"Methods Enzymol."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2024.111015_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(94)90012-4","article-title":"Liposomes mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications","volume":"174","author":"Van Rooijen","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cbi.2024.111015_bib28","article-title":"3,5,3'-Triiodothyronine-Loaded liposomes inhibit hepatocarcinogenesis via inflammation-associated macrophages","volume":"12","author":"Sun","year":"2022","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.cbi.2024.111015_bib29","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1172\/JCI81203","article-title":"STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma","volume":"125","author":"Li","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"21","key":"10.1016\/j.cbi.2024.111015_bib30","doi-asserted-by":"crossref","first-page":"9702","DOI":"10.7150\/thno.44297","article-title":"Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder","volume":"10","author":"Hu","year":"2020","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.cbi.2024.111015_bib31","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41401-020-00597-x","article-title":"Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis","volume":"42","author":"Chen","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.cbi.2024.111015_bib32","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2024.111015_bib33","article-title":"Antifibrotic effects of kangxian ruangan capsule on rats with nonalcoholic fatty liver fibrosis and hepatic stellate cells through regulation of TGF-beta and TLR4 signaling pathways","volume":"2021","author":"Liu","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"issue":"7","key":"10.1016\/j.cbi.2024.111015_bib34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.cbi.2024.111015_bib35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.30249","article-title":"Pharmacological inhibition of CCR2\/5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice","volume":"69","author":"Ambade","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cbi.2024.111015_bib36","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.cbi.2024.111015_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.cbi.2024.111015_bib38","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1039\/D1BM01663F","article-title":"Clodronate-nintedanib-loaded exosome-liposomes hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity","volume":"10","author":"Ji","year":"2022","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.cbi.2024.111015_bib39","first-page":"230","article-title":"Exploration of the phagocytic function of the reticuloendothelial system with heat denatured human serum albumin labeled with I131 and application to the measurement of liver blood flow, in normal man and in some pathologic conditions","volume":"51","author":"Biozzi","year":"1958","journal-title":"J. Lab. Clin. Med."},{"issue":"3","key":"10.1016\/j.cbi.2024.111015_bib40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1023\/A:1018965121222","article-title":"Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes","volume":"11","author":"Harashima","year":"1994","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"4","key":"10.1016\/j.cbi.2024.111015_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.etp.2017.01.005","article-title":"Attenuation of alpha-naphthylisothiocyanate (ANIT)-induced biliary fibrosis by depletion of hepatic macrophages in rats","volume":"69","author":"Golbar","year":"2017","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.cbi.2024.111015_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120761","article-title":"Clodronate-loaded liposomal and fibroblast-derived exosomal hybrid system for enhanced drug delivery to pulmonary fibrosis","volume":"271","author":"Sun","year":"2021","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.cbi.2024.111015_bib43","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s11095-021-03079-9","article-title":"Size-dependent absorption through stratum corneum by drug-loaded liposomes","volume":"38","author":"Liu","year":"2021","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.cbi.2024.111015_bib44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","article-title":"Liposomes: advancements and innovation in the manufacturing process","volume":"154\u2013155","author":"Shah","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.cbi.2024.111015_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1039\/D0NH00605J","article-title":"Targeted liposomal drug delivery: a nanoscience and biophysical perspective","volume":"6","author":"Liu","year":"2021","journal-title":"Nanoscale Horiz"},{"key":"10.1016\/j.cbi.2024.111015_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.cbi.2024.111015_bib47","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jhep.2014.02.003","article-title":"Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma","volume":"60","author":"Coulouarn","year":"2014","journal-title":"J. Hepatol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724001613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724001613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:01:04Z","timestamp":1777392064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724001613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":47,"alternative-id":["S0009279724001613"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111015","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipopolysaccharide modification enhances the inhibitory effect of clodronate liposomes on hepatic fibrosis by depletion of macrophages and hepatic stellate cells","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111015"}}